BDMAI

Infinite Right-to-Left Scrolling Marquee
Latest Circulars

Availability of QC Manpower trained in BDMA T & T Center

Sectoral Plan for Effective Logistics – Pharma Sector

BDMAI News Letter – Material contribution by Members

Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.

Pharma MSME Industry Meet – 24.1.2025

Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB

MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education

Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025

Allotment of land in Green Pharma City, Telangana

Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India

New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs

Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies

ICH Guidelines- Q7- Telugu Translated version

Special offer by Avila International – Travel Package – CPhI China

Online Application for implementation of Schedule M

Simplification of license procedure to manufacture new drug or investigational new drug for clinical trial or bioavailability or bioequivalence study or for examination, test and analysis

Workshop for Bench Chemists

Nomination for Internal Committees of BDMAI

Availability of QC Manpower trained in BDMA T & T Center

Sectoral Plan for Effective Logistics – Pharma Sector

BDMAI News Letter – Material contribution by Members

Interaction with USP, India team with our Member companies on 9.1.2025 at 2.00 p.m.

Pharma MSME Industry Meet – 24.1.2025

Delays in obtaining URN / Permission for Destruction of Controlled Substances from NCB

MOU Signing Ceremony between BDMAI and Telangana Council of Higher Education

Implementation of Schedule M – Online Demo by CDSCO for filling application on 14th February 2025

Allotment of land in Green Pharma City, Telangana

Launch of a Scheme for Promotion of Research & Innovation in Pharma MedTech (PRIP) Sector by Department of Pharmaceuticals, Govt. of India

New Guidelines for obtaining NoC for Export of Unapproved/Approved New Drugs

Free In-House Up-Skilling Programme by LSSSDC for Employees BDMAI Member companies

ICH Guidelines- Q7- Telugu Translated version

Special offer by Avila International – Travel Package – CPhI China

Online Application for implementation of Schedule M

Simplification of license procedure to manufacture new drug or investigational new drug for clinical trial or bioavailability or bioequivalence study or for examination, test and analysis

Workshop for Bench Chemists

Nomination for Internal Committees of BDMAI

Internal Committee

S.NO COMMITTEE NAME COMPANY NAME NAME OF PERSON Email
1
Regulatory
Granules India Ltd
Mr.Sridhar Reddy Karra
sridharreddy.karra@granulesindia.com
2
Regulatory
MSN Group
Mr. Kadari  Ravinder Reddy 
 krreddy@msnlabs.com
3
Regulatory
Laxai Life Sciences Pvt. Ltd.
Mr. Narayana Reddy Jarugu
jnarayanareddy@laxai.com
4
EHS
Granules India Ltd
Mr.Kishore Reddy Alluri
kishorereddy.alluri@granulesindia.com
5
EHS
Aurobindo Pharma Ltd
Mr. Tapas Saha
tapas.Saha@apitoria.com
6
EHS
Apitoria Pharma
Mr. Amar Kudale
amar.Kudale@apitoria.com
7
EHS
Hetero Group
Mr. Hari Bukia
hari.b@hetero.com
8
EHS
MSN Group
 Mr. Muthyala Surender Reddy
 surender.muthyala@msnlabs.com
9
EHS
MSN Group
Mr. Nagamalleshwar rao 
malleswararao.sandepudi@msnlabs.com
10
EHS
Laxai Life Sciences Pvt. Ltd.
 Mr. Nagendra Babu B
nagendrababu.b@laxai.com
11
Commercial
Granules India Ltd
Mr.Sathyanarayana Jettem
 jsnarayaana@granulesindia.com
12
Commercial
Rampex Labs Pvt Ltd
Mr. G Venkateswara Rao
gvrao@rampexlabs.com
13
Exports
Granules India Ltd
Mr.Khaleel Shaik
 khaleel.shaik@granulesindia.com
14
Exports
MSN Group
Mr. Kalvakol Ragava Reddy 
raghavareddy.k@msnlabs.com
15
Exports
Piramal Pharma Ltd
Mr. Minoo Biju
minoo.biju@piramal.com
16
Exports
Piramal Pharma Ltd
Mr. Neelam Sharma
neelam.sharma@piramal.com

© 2021 Templately copyright all right reserved